PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.
H2020 FET Open
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
PrimoGAIA Interviews – Sabrina Elkhanoufi
PrimoGAIA Interviews - Sabrina Elkhanoufi...
PrimoGAIA Interviews – Florian Fidler
PrimoGAIA Interviews - Florian Fidler...
PrimoGAIA Interviews – Dahmane Boudries
PrimoGAIA Interviews - Dahmane Boudries...
PrimoGAIA Interviews – Sarah Garifo
PrimoGAIA Interviews - Sara Garifo...
PrimoGAIA Interviews – Seda Seren
PrimoGAIA Interviews - Seda Seren...
Chemistry – A European Journal: Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
Published in Chemistry Europe...
PrimoGAIA 2nd Review meeting
The 2nd PrimoGAIA Project Review meeting was successfully held on 26th January 2022....
Nanoscale journal: Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging
Published in the Nanoscale journal...
Journal of Magnetic Resonance: Enzymatic activity monitoring through dynamic nuclear polarization in Earth magnetic field
Published in the Journal of Magnetic Resonance...